BioGend Therapeutics Co., Ltd. (TPEX:6733)
Taiwan
· Delayed Price · Currency is TWD 35.50
-0.90 (-2.47%)
At close: Mar 9, 2026
BioGend Therapeutics Market Cap
BioGend Therapeutics has a market cap or net worth of 4.41 billion as of March 9, 2026. Its market cap has increased by 4.65% in one year.
Market Cap
4.41B
Enterprise Value
3.92B
Revenue
222.34M
Ranking
n/a
PE Ratio
n/a
Stock Price
35.50
Market Cap Chart
Since June 18, 2019, BioGend Therapeutics's market cap has increased from 2.71B to 4.41B, an increase of 62.65%. That is a compound annual growth rate of 7.50%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Senhwa Biosciences | 4.62B |
| Medigen Biotechnology | 4.20B |
| Energenesis Biomedical CO.,LTD. | 4.18B |
| Formosa Pharmaceuticals | 4.08B |
| UnicoCell Biomed | 5.09B |
| Genovate Biotechnology | 3.94B |
| Pharmosa Biopharm | 5.23B |
| OBI Pharma | 5.23B |